# Intensive Monitoring Scheme of Lidocaine Cataplasms

> **NCT05645302** · — · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Adverse Reaction to Drug

## Interventions

- **DRUG:** Lidocaine Cataplasms

## Key facts

- **NCT ID:** NCT05645302
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-06
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645302, "Intensive Monitoring Scheme of Lidocaine Cataplasms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05645302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*